Litigation Details for OHEMO LIFE SCIENCES, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2019)
✉ Email this page to a colleague
OHEMO LIFE SCIENCES, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-04-19 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-08-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Madeline Cox Arleo |
| Jury Demand | None | Referred To | Michael A. Hammer |
| Parties | TEVA PHARMACEUTICALS USA, INC. | ||
| Patents | 7,955,619 | ||
| Link to Docket | External link to docket | ||
Details for OHEMO LIFE SCIENCES, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-04-19 | 1 | Complaint | infringement of United States Patent No. 7,955,619 (“the ’619 patent”). This action arises out of Defendants…Its Paragraph IV Certification that U.S. Patent No. 7,955,619 Is Invalid, Unenforceable and/or Not Infringed… 8. This civil action for patent infringement arises under the patent laws of the United States, including… THE PATENT-IN-SUIT 20. The ’619 patent, entitled “Abuse Resistant …619 patent is listed in the Orange Book in connection with approved NDA No. 206544, as a patent “with | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
